Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improvements in eliciting dose across baseline sensitivities following 12 months of epicutaneous immunotherapy (EPIT) in peanut-allergic children aged 4 to 11 years.
Greenhawt M, Kim EH, Campbell DE, Green TD, Lambert R, Fleischer DM. Greenhawt M, et al. Among authors: kim eh. J Allergy Clin Immunol Pract. 2020 Oct;8(9):3219-3221. doi: 10.1016/j.jaip.2020.05.030. Epub 2020 Jun 2. J Allergy Clin Immunol Pract. 2020. PMID: 32502548 Free article. No abstract available.
Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison.
Chin SJ, Vickery BP, Kulis MD, Kim EH, Varshney P, Steele P, Kamilaris J, Hiegel AM, Carlisle SK, Smith PB, Scurlock AM, Jones SM, Burks AW. Chin SJ, et al. Among authors: kim eh. J Allergy Clin Immunol. 2013 Aug;132(2):476-8.e2. doi: 10.1016/j.jaci.2013.02.017. Epub 2013 Mar 25. J Allergy Clin Immunol. 2013. PMID: 23534975 Free PMC article. Clinical Trial. No abstract available.
Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective.
Vickery BP, Berglund JP, Burk CM, Fine JP, Kim EH, Kim JI, Keet CA, Kulis M, Orgel KG, Guo R, Steele PH, Virkud YV, Ye P, Wright BL, Wood RA, Burks AW. Vickery BP, et al. Among authors: kim ji, kim eh. J Allergy Clin Immunol. 2017 Jan;139(1):173-181.e8. doi: 10.1016/j.jaci.2016.05.027. Epub 2016 Aug 10. J Allergy Clin Immunol. 2017. PMID: 27522159 Free PMC article. Clinical Trial.
Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial.
Bird JA, Spergel JM, Jones SM, Rachid R, Assa'ad AH, Wang J, Leonard SA, Laubach SS, Kim EH, Vickery BP, Davis BP, Heimall J, Cianferoni A, MacGinnitie AJ, Crestani E, Burks AW; ARC001 Study Group. Bird JA, et al. Among authors: kim eh. J Allergy Clin Immunol Pract. 2018 Mar-Apr;6(2):476-485.e3. doi: 10.1016/j.jaip.2017.09.016. Epub 2017 Oct 31. J Allergy Clin Immunol Pract. 2018. PMID: 29092786 Free article. Clinical Trial.
The importance of reducing risk in peanut allergy: Current and future therapies.
Shreffler WG, Baumert JL, Remington BC, Koppelman SJ, Dinakar C, Fleischer DM, Kim E, Tilles SA, Spergel JM. Shreffler WG, et al. Ann Allergy Asthma Immunol. 2018 Feb;120(2):124-127. doi: 10.1016/j.anai.2017.10.038. Epub 2017 Dec 28. Ann Allergy Asthma Immunol. 2018. PMID: 29289463 No abstract available.
Recurrent anaphylaxis during cardiac catheterization due to ethylene oxide.
Hamad A, Iweala OI, Henderson C, Madan S, Stouffer GA 3rd, Commins SP, Kim EH. Hamad A, et al. Among authors: kim eh. J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2148-2150. doi: 10.1016/j.jaip.2018.04.017. Epub 2018 Apr 30. J Allergy Clin Immunol Pract. 2018. PMID: 29715563 Free PMC article. No abstract available.
2,115 results